Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.500
+0.220 (6.71%)
Nov 7, 2024, 3:26 PM EST - Market open
Lantern Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 5.62 | 5.98 | 5.83 | 5.02 | 3.66 | 1.48 | |
| Research & Development | 13.92 | 11.89 | 8.6 | 6.57 | 2.24 | 0.95 | |
| Operating Expenses | 19.54 | 17.88 | 14.43 | 11.59 | 5.91 | 2.43 | |
| Operating Income | -19.54 | -17.88 | -14.43 | -11.59 | -5.91 | -2.43 | |
| Interest & Investment Income | 0.9 | 0.77 | 0.2 | 0.07 | - | - | |
| Other Non Operating Income (Expenses) | 0.9 | 1.15 | -0.03 | 0.05 | - | - | |
| EBT Excluding Unusual Items | -17.73 | -15.96 | -14.26 | -11.47 | -5.91 | -2.43 | |
| Other Unusual Items | - | - | - | -0.89 | - | - | |
| Pretax Income | -17.75 | -15.96 | -14.26 | -12.36 | -5.91 | -2.43 | |
| Net Income | -17.75 | -15.96 | -14.26 | -12.36 | -5.91 | -2.43 | |
| Net Income to Common | -17.75 | -15.96 | -14.26 | -12.36 | -5.91 | -2.43 | |
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 4 | 2 | |
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 4 | 2 | |
| Shares Change (YoY) | -0.58% | -0.08% | -0.50% | 153.31% | 117.61% | 2.67% | |
| EPS (Basic) | -1.64 | -1.47 | -1.31 | -1.13 | -1.37 | -1.23 | |
| EPS (Diluted) | -1.64 | -1.47 | -1.31 | -1.13 | -1.37 | -1.23 | |
| Free Cash Flow | -15.27 | -14.37 | -12.8 | -10.61 | -5.67 | -2.13 | |
| Free Cash Flow Per Share | -1.42 | -1.32 | -1.18 | -0.97 | -1.32 | -1.08 | |
| EBITDA | -19.53 | -17.86 | -14.42 | -11.58 | -5.9 | -2.43 | |
| D&A For EBITDA | 0.02 | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| EBIT | -19.54 | -17.88 | -14.43 | -11.59 | -5.91 | -2.43 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.